MH-06
MH-06 is an orally active 12-lipoxygenase (ALOX12) PROTAC degrader. MH-06 specifically binds to ALOX12 and recruits E3 ubiquitin ligase to mediate ubiquitination and degradation of the target protein. MH-06 inhibits the MAPK signaling pathway, reduces the production of reactive oxygen species (ROS), restores mitochondrial function, regulates macrophage polarization and decreases the release of pro-inflammatory cytokines. MH-06 can be used for the research of acute pancreatitis.
(Pink: 12-LOX ligand (HY-187183); Blue: Cereblon ligand (HY-10984); Black: linker).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C30H27N7O7
- Molecular Weight:597.58
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
12-LOX |
Cereblon |
In Vitro
MH-06 (1.25-20.0 μM; 24 h) dose-dependently degrades ALOX12 protein in LPS (HY-D1056)-induced inflammatory AR42J rat pancreatic exocrine cells[1].
MH-06 (10.0 μM; 24 h) significantly reduces intracellular 12-HETE production in LPS-induced inflammatory AR42J rat pancreatic exocrine cells[1].
MH-06 (10.0 μM; 24 h) significantly reduces the transcription levels of pro-inflammatory factors TNF-α, IL-6 and chemokine CCL2 in LPS-induced inflammatory AR42J rat pancreatic exocrine cells[1].
MH-06 (5.0-10.0 μM; 24 h) reduces LPS-induced reactive oxygen species (ROS) production in inflammatory AR42J rat pancreatic exocrine cells in a dose-dependent manner, with the ROS level in the 10.0 μM MH-06 treatment group being 65.4% lower than that in the LPS-induced control group[1].
MH-06 (5.0-10.0 μM; 24 h) dose-dependently restores the mitochondrial membrane potential of LPS-induced inflammatory AR42J rat pancreatic exocrine cells and improves mitochondrial function[1].
MH-06 (5.0-10.0 μM; 24 h) dose-dependently inhibits the phosphorylation-dependent activation of the ERK and P38 branches of the MAPK signaling pathway in LPS-induced inflammatory AR42J rat pancreatic exocrine cells, without affecting the total ERK or P38 protein levels[1].
MH-06 (5.0-10.0 μM; 24 h) dose-dependently reduces the protein expression levels of pyroptosis markers Caspase-1, NLRP3 and ASC in LPS-induced inflammatory AR42J rat pancreatic exocrine cells[1].
MH-06 (treated at concentrations of 5.0-10.0 μM for 12 hours following 24-hour LPS stimulation) dose-dependently regulates LPS-stimulated RAW264.7 murine macrophages by reducing M1 polarization and enhancing M2 polarization, while inhibiting the secretion of pro-inflammatory INF-γ[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:LPS-induced inflammatory AR42J rat pancreatic exocrine cells
-
Concentration:1.25, 2.5, 5.0, 10.0, 15.0, 20.0 μM
-
Incubation Time:24 h
-
Result:Nearly achieved complete degradation of ALOX12 protein at 10.0 μM.
Showed significant degradation activity at 5.0 μM, with almost complete degradation occurring at 10.0 μM and higher concentrations.
Confirmed dose-dependent reduction in ALOX12 protein levels relative to β-actin.
-
Cell Line:LPS-induced inflammatory AR42J rat pancreatic exocrine cells
-
Concentration:10.0 μM
-
Incubation Time:24 h
-
Result:Significantly inhibited the transcriptional levels of TNF-α, IL-6, and CCL2 compared to the LPS-induced control group.
-
Cell Line:LPS-induced inflammatory AR42J rat pancreatic exocrine cells
-
Concentration:5.0, 10.0 μM
-
Incubation Time:24 h
-
Result:Had no significant effect on total ERK and P38 protein levels.
Significantly inhibited the expression of phosphorylated ERK (p-ERK) and phosphorylated P38 (p-P38) in a concentration-dependent manner, with higher concentrations showing greater inhibitory activity.\nSignificantly reduced the protein expression levels of Caspase-1, NLRP3, and ASC in a concentration-dependent manner.
Showed the strongest inhibitory effect at 10.0 μM.
In Vivo
Compared with single-dose administration, MH-06 (60 mg/kg; p.o.; administered twice) exerts superior preventive and therapeutic effects on caerulein-induced acute pancreatitis in C57BL/6J mice[1].
MH-06 (200-400 mg/kg; p.o.; single administration) shows good tolerance in C57BL/6J mice. With a single intragastric dose up to 400 mg/kg, no acute toxicity or adverse reactions are observed during the 7-day observation period[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J mice (18-22 g, healthy)[1]
-
Dosage:30 mg/kg; 60 mg/kg; 90 mg/kg
-
Administration:p.o.; single dose
-
Result:Reduced serum amylase, serum lipase, pancreatic trypsin activity, and pancreatic myeloperoxidase (MPO) activity in a dose-dependent manner.
Decreased serum amylase by 44.89%, serum lipase by 49.58%, pancreatic trypsin activity by 50.79%, and pancreatic MPO activity by 56.80% at 90 mg/kg compared to untreated cerulein-induced AP mice.
Alleviated pancreatic edema, inflammatory cell infiltration, and acinar cell necrosis in a dose-dependent manner, with the 90 mg/kg group showing the most significant improvement in pancreatic tissue damage.
-
Animal Model:C57BL/6J mice (18-22 g, healthy)[1]
-
Dosage:60 mg/kg
-
Administration:p.o.; two doses: 1 hour pre-modeling and 6 hours post-final cerulein injection
-
Result:Exerted a significantly stronger inhibitory effect on acute pancreatitis compared to the single intervention group, though its efficacy was slightly lower than that of the single 90 mg/kg MH-06 dose group.
-
Animal Model:C57BL/6J mice (18-22 g, healthy)[1]
-
Dosage:200 mg/kg; 300 mg/kg; 400 mg/kg
-
Administration:p.o.; single dose
-
Result:Showed no abnormal behavioral or physical manifestations in any dose group within 24 hours.
Maintained normal mental status, locomotor activity, food intake, and showed no significant body weight fluctuations over the 7-day observation period.
Chemical Information
-
Molecular Weight 597.58
-
Formel C30H27N7O7
-
SMILES
O=C1CCC(C(N1)=O)N2C(C3=C(C(NC(CN4CCN(CC4)CC5=NC6=C(C(N5)=O)OC7=CC=CC=C76)=O)=CC=C3)C2=O)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
LPS-Induced Endotoxemia/Systemic Inflammation
Lipopolysaccharide (LPS)-induced endotoxemia is a widely used in vivo model of acute systemic inflammation in which LPS, a Gram-negative bacterial endotoxin, activates innate immune signaling primarily through TLR4, leading to rapid and transient induction of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β in circulation and tissues. This cytokine surge is commonly used as a measurable readout of systemic inflammatory activation and immune dysregulation, and is typically assessed within hours after intraperitoneal LPS administration in mouse models of endotoxemia. The model captures key features of systemic inflammatory response syndrome, including cytokine release, immune cell activation, and downstream tissue responses, and has been used to evaluate anti-inflammatory interventions such as cytokine modulation, lipid mediators, and immune cell-targeting therapies.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Primary monocyte-to-macrophage differentiation
Primary human monocytes can be differentiated ex vivo into monocyte-derived macrophages by culturing purified blood monocytes for approximately 5-7 days in macrophage-supporting cytokine conditions; M-CSF commonly yields CD14^high/CD163^high macrophages, while GM-CSF yields a phenotypically distinct macrophage population, so the cytokine condition should be chosen according to the downstream model. The readout of successful differentiation is a combined change in morphology, adherence, surface phenotype, and function: differentiated macrophages become adherent, enlarge, acquire macrophage-associated markers such as CD14, CD68, CD163, CD206, or HLA-DR depending on culture condition, and show increased phagocytic capacity compared with starting monocytes.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)